Driving season is upon us, but we haven't seen the rise in gas prices we might have expected. It may be on the horizon -- here's what to watch for. More
3 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of three Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
U.S. Households Still a Long Way From Wealth Recovery
Americans are still well below their household levels of wealth from 2007, despite stock market gains and a slowly growing economy. More
Americans Are Eating and Drinking Again: How to Play It
U.S. consumers are eating out more -- but don't blindly buy the restaurant stocks. A careful look at demographic trends reveals some winners amid the also-rans. More
The Utica Is Quite ‘Gassy’ … And That’s OK
The Utica was touted to bring in $500 billion for the energy industry, but so far has come up short on shale oil. Can natural gas reserves save its investors? More
4 Chemicals Stocks to Sell Now
The overall ratings of four Chemicals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Johnson & Johnson Is One Must Own Dividend Stock
Johnson & Johnson has delivered steady dividend increases for the last 50 years, a track record that makes it a stalwart for dividend portfolios More
